Should all precancerous cervical lesions be treated

Whether cervical precancerous lesions need treatment depends on the severity of the lesion. In general, CIN 2 and CIN 3, HPV persistent infection, and patients with greater psychological stress need treatment. Whether cervical precancerous lesions need treatment depends on the severity of the lesion. In general, the following conditions need treatment: 1. CIN1: Treatment is usually not required, and doctors recommend regular cytology and HPV testing to monitor the progression of the disease.2. CIN2 and CIN 3: These are high-grade precancerous lesions that require treatment. Treatment includes loop electrosurgical excision (LEEP), cold knife conization, etc. Regular review is still required after treatment to ensure complete clearance of lesions. 3. HPV persistent infection: If HPV test results are positive and persistent infection exceeds 1 year, treatment is required even if cytological results are normal. Treatment methods are mainly antiviral therapy. 4. Patients with greater psychological pressure: For some patients with psychological stress, even if the lesion is mild, treatment may be chosen. It should be noted that not all precancerous cervical lesions will develop into cervical cancer. Most lesions will regress after a period of time or return to normal after treatment. Therefore, regular cervical cancer screening is very important to detect lesions early and treat them promptly. In addition, for some special groups, such as young women, women with fertility needs, etc., the choice of treatment methods needs to be more cautious. Doctors will weigh the pros and cons of treatment according to the specific conditions of patients and formulate personalized treatment plans. In short, whether precancerous lesions of the cervix need treatment requires comprehensive consideration of the severity of the lesions, the age of the patient, fertility needs and other factors. Patients should follow the doctor's advice for regular check-ups and treatments to prevent cervical cancer.